| Product Code: ETC13140003 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa mRNA Vaccine and Therapeutics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa mRNA Vaccine and Therapeutics Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Africa mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Africa mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Africa mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa mRNA Vaccine and Therapeutics Market Trends |
6 Africa mRNA Vaccine and Therapeutics Market, 2021 - 2031 |
6.1 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021 - 2031 |
6.1.3 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021 - 2031 |
6.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Cancer, 2021 - 2031 |
6.2.3 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.2.4 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.2.5 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Other, 2021 - 2031 |
6.3 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Monoclonal Antibody, 2021 - 2031 |
6.3.3 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.3.4 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Cell Therapy, 2021 - 2031 |
6.3.5 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Other, 2021 - 2031 |
6.4 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Research Laboratories and Organizations, 2021 - 2031 |
6.4.3 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.4 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.5 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Africa mRNA Vaccine and Therapeutics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.1 South Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.2 Egypt mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.3 Nigeria mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.2.4 Rest of Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Vaccine Type, 2021 - 2031 |
7.3 Africa mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 South Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Egypt mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 Nigeria mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Rest of Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.1 South Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.2 Egypt mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.3 Nigeria mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4.4 Rest of Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.1 South Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.2 Egypt mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.3 Nigeria mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
7.5.4 Rest of Africa mRNA Vaccine and Therapeutics Market, Revenues & Volume, By End user, 2021 - 2031 |
8 Africa mRNA Vaccine and Therapeutics Market Key Performance Indicators |
9 Africa mRNA Vaccine and Therapeutics Market - Export/Import By Countries Assessment |
10 Africa mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
10.1 Africa mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
10.3 Africa mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Africa mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.5 Africa mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
11 Africa mRNA Vaccine and Therapeutics Market - Competitive Landscape |
11.1 Africa mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2022 |
11.2 Africa mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here